Oncolytics Biotech® Starts Enrolment in U.S. Phase 2 Pancreatic Cancer Clinical Trial

News   May 27, 2010

 
Oncolytics Biotech® Starts Enrolment in U.S. Phase 2 Pancreatic Cancer Clinical Trial
 
 
 

RELATED ARTICLES

Researchers Discover Key Link Between Mitochondria and Cocaine Addiction

News

Researchers were able to block response in mitochondria to cocaine.

READ MORE

Tuberculosis Vaccine Trial Results Offer Potential for BCG Revaccination

News

The study is the first 'prevention of infection' trial conducted for tuberculosis, the world's leading infectious disease killer.

READ MORE

Researchers Test Drug Transfer Using Placenta-On-A-Chip

News

Researchers have demonstrated the feasibility of their "organ-on-a-chip" platform in studying how drugs are transported across the human placental barrier.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE